The Molecular Pathology of Non-Malignant Haematological Disease - Top-Institutions - MDSpire

The Molecular Pathology of Non-Malignant Haematological Disease

  • By

  • A. D. Blann

  • R. G. Dunn

  • May 22, 2026

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Cincinnati Children’s Hospital Medical Center
    Cincinnati Children’s Hospital Medical Center

    Cincinnati, Ohio

    Key Differentiators

    • Hematology
    • Pediatric Hematology/Oncology

  • #2

    Children’s Hospital of Philadelphia
    Children’s Hospital of Philadelphia

    Philadelphia, Pennsylvania

    Key Differentiators

    • Hematology
    • Pediatric Hematology/Oncology

Original Source(s)

The Molecular Pathology of Non-Malignant Haematological Disease

  • by A. D. Blann, R. G. Dunn

  • May 22, 2026

Related Content

A Comprehensive Review of Monoclonal Gammopathy of Undetermined Significance

Approximately 3% to 4% of the population over the age of 50 is diagnosed with monoclonal gammopathy of undetermined significance (MGUS). It carries a lifelong risk of progression to multiple myeloma and lymphoma, requiring risk-adapted monitoring by multidisciplinary teams.

Clinical Reasoning in Practice: Implementing High-Value Care When Data Discrepancies Arise

Evaluation of gecacitinib vs hydroxyurea in patients with intermediate-2 or high-risk myelofibrosis: final analysis results from a randomized phase 3 study